USPTO Examiner PYLE SIENNA CHRISTINE - Art Unit 3791

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19103450SPECTROMETRY SYSTEMS AND METHODSFebruary 2025January 2026Allow1100NoNo
18369562EYESHADE STRUCTURE FOR BILIRUBIN DETECTIONSeptember 2023October 2025Allow2500NoNo
18017706METHOD AND DEVICE FOR DETERMINING A CORONARY MICROVASCULAR RESISTANCE SCOREJanuary 2023January 2026Allow3610NoNo
18081360SYSTEM AND METHOD OF TESTING A HEARING FUNCTIONDecember 2022December 2025Abandon3610NoNo
18052194SENSING SYSTEMS AND METHODS FOR PROVIDING DIABETES DECISION SUPPORT USING CONTINUOUSLY MONITORED ANALYTE DATANovember 2022December 2025Allow3810YesNo
17922496CAPSULE FOR FLUID SAMPLING AND DRUG DELIVERYOctober 2022December 2025Abandon3710NoNo
17947823Distributed Sensor Network for Measurement of Biometric ParameterSeptember 2022November 2025Allow3810NoNo
17911345ELECTRONIC DEVICESeptember 2022January 2026Allow4020NoNo
17905587NON-INVASIVE WEARABLE SENSOR DEVICE FOR DETECTING BIOMARKERS IN SECRETIONSeptember 2022December 2025Abandon4010NoNo
17904672BLOOD PRESSURE PREDICTION METHOD AND DEVICEAugust 2022July 2025Allow3510NoNo
17885812SYSTEM, DEVICE AND METHOD FOR DETERMINING AND/OR ASSESSING BRAIN RELATED CONDITIONS BASED ON PUPIL LIGHT RESPONSEAugust 2022August 2025Allow3610NoNo
17795617METHOD FOR DETERMINING ACCURACY OF HEART RATE VARIABILITYJuly 2022November 2025Abandon3910NoNo
17811019HEAD INJURY ASSESSMENT BASED ON COMNINATIONS OF BIOMARKERS, COGNITIVE ASSESSMENT AND/OR IMPACT DETECTIONJuly 2022August 2025Abandon3701NoNo
17856528SYSTEMS AND METHODS FOR EVALUATING AND MITIGATING PROBLEM BEHAVIOR BY DETECTING PRECURSORSJuly 2022June 2025Allow3610YesNo
17841430ABNORMAL GAIT DETECTION BASED ON 2D HUMAN POSE ESTIMATIONJune 2022February 2026Allow4410NoNo
17837357SMART MULTI-MODAL TELEHEALTH-IOT SYSTEM FOR RESPIRATORY ANALYSISJune 2022July 2025Allow3710NoNo
17746475Systems for Determining Similarity of Sequences of Glucose ValuesMay 2022August 2025Allow3910YesNo
17746392FLUID COLLECTION DEVICEMay 2022October 2025Allow4110NoNo
17777057METHOD AND APPARATUS FOR ESTABLISHING ABSENCE OF PAIN IN A MAMMALMay 2022May 2025Allow3610NoNo
17733633TESTING METHOD, SYSTEM AND DEVICE FOR FLICKER FUSION FREQUENCY RANGEApril 2022September 2025Abandon4110NoNo
17772215MEANS AND METHODS FOR ASSESSING HUNTINGTON'S DISEASE OF THE PRE-MANIFEST STAGEApril 2022February 2026Allow4620NoNo
17771082PROCESSING PHYSIOLOGICAL SIGNALS TO DETERMINE HEALTH-RELATED INFORMATIONApril 2022October 2025Abandon4210NoNo
17715490ELECTROMYOGRAPHIC BRUXISM TRAININGApril 2022August 2025Allow4000NoNo
17765794MEDICAL INSTRUMENT FOR TAKING TISSUE SAMPLES IN THE BODYMarch 2022August 2025Allow4010NoNo
17692407MENSTRUAL CYCLE TRACKINGMarch 2022October 2025Allow4320YesNo
17679037OPTICAL DETECTION DEVICEFebruary 2022July 2025Allow4120NoNo
17636429A METHOD AND APPARATUS FOR PROCESSING ASTHMA PATIENT COUGH SOUND FOR APPLICATION OF APPROPRIATE THERAPYFebruary 2022September 2025Allow4310NoNo
17636298SYSTEMS AND METHODS FOR EVALUATING PUPILLARY RESPONSEFebruary 2022October 2025Allow4410NoNo
17668722Systems and Methods for Calibration of an Optical Measurement SystemFebruary 2022June 2025Allow4010NoNo
17633227IDENTIFYING A BODY PARTFebruary 2022July 2025Allow4110NoNo
17633418BODY MONITORING SYSTEM COMPRISING A MICRO-NEEDLEFebruary 2022September 2025Allow4420NoNo
17631157OCULAR BIOMECHANICAL PROPERTIES MEASURING AND MONITORING DEVICEJanuary 2022July 2025Allow4220NoNo
17552496SIZER FOR MEASURING AN ANATOMICAL STRUCTURE, WITH DIGITAL MONITORING, DISPLAY, RECORDING, AND COMMUNICATING SYSTEMDecember 2021March 2025Allow3910YesNo
17553181NON-INVASIVE SENSOR AND METHOD FOR DETERMINING BLOOD GLUCOSEDecember 2021March 2025Allow3910NoNo
17552351REMOTE MONITORING OF RESPIRATORY FUNCTION USING A CLOUD-BASED MULTIMODAL DIALOGUE SYSTEMDecember 2021April 2025Abandon4010NoNo
17552250Smart Bag to Measure Urine Output Via CatheterDecember 2021May 2025Allow4120YesNo
17644150BREATH SAMPLING SYSTEMDecember 2021March 2025Abandon3901NoNo
17527673DETECTION DEVICE AND WALKING SUPPORT SYSTEMNovember 2021April 2025Abandon4110NoNo
17516167MACHINE LEARNING TECHNIQUES FOR OPTIMIZED BREATHING THERAPYNovember 2021August 2025Allow4610YesNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner PYLE, SIENNA CHRISTINE - Prosecution Strategy Guide

Executive Summary

Examiner PYLE, SIENNA CHRISTINE works in Art Unit 3791 and has examined 7 patent applications in our dataset. With an allowance rate of 57.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 40 months.

Allowance Patterns

Examiner PYLE, SIENNA CHRISTINE's allowance rate of 57.1% places them in the 18% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by PYLE, SIENNA CHRISTINE receive 1.00 office actions before reaching final disposition. This places the examiner in the 9% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by PYLE, SIENNA CHRISTINE is 40 months. This places the examiner in the 25% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +75.0% benefit to allowance rate for applications examined by PYLE, SIENNA CHRISTINE. This interview benefit is in the 99% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 50.0% of applications are subsequently allowed. This success rate is in the 98% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 4% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 48% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 50% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.